Previous Page  22 / 28 Next Page
Information
Show Menu
Previous Page 22 / 28 Next Page
Page Background

Predicting neurofibromatosis type 1 risk

among children with isolated café-au-lait

macules

Journal of the American Academy of Dermatology

Take-home message

The authors of this retrospective study developed an algorithm to predict the risk for neurofibromatosis type 1 (NF1) based on

age, the number of café-au-lait macules (CALMs), and the presence of atypical CALMs (irregular margins and ragged borders)

in children with isolated CALMs. Children older than 29 months with one or more atypical CALM but fewer than six CALMs had

a 0.9% risk of NF1. In contrast, children younger than 29 months with six or more CALMs had an 80.4% risk of NF1.

The presence of more than six CALMs in a child younger than 2.5 years of age is associated with a high risk of NF1. An algorithm

incorporating age, number of CALMs, and presence of atypical CALMs allows for an accurate NF1 risk assessment in children

with isolated CALMs.

Abstract

BACKGROUND

Although isolated café-au-lait mac-

ules (CALMs) are a common skin finding, they are

an early feature of neurofibromatosis type 1 (NF1).

OBJECTIVE

We sought to develop an algorithm

determining the risk of children with CALMs to

have constitutional NF1.

METHODS

We conducted a retrospective study of

patients with isolated CALMs. Diagnosis of NF1

was based on detecting NF1 mutation in blood

or fulfilling clinical criteria.

RESULTS

In all, 170 of 419 (41%) and 21 of 86 (24%)

children with isolated CALMs who underwent

molecular testing and clinical follow-up, respec-

tively, were given a diagnosis of NF1. Presence

of fewer than 6 CALMs at presentation or atyp-

ical CALMs was associated with not having NF1

(P < 0.001). An algorithm based on age, CALMs

number, and presence of atypical macules

predicted NF1 in both cohorts. According to the

algorithm, children older than 29 months with at

least 1 atypical CALM or less than 6 CALMs have

a 0.9% (95% confidence interval 0–2.6%) risk

for constitutional NF1 whereas children younger

than 29 months with 6 or more CALMs have

a high risk (80.4%, 95% confidence interval

74.6–86.2%).

LIMITATIONS

The study was designed to detect

constitutional NF1 and not NF1 in mosaic form.

CONCLUSIONS

A simple algorithm enables cat-

egorization of children with isolated CALMs as

being at low or high risk for having NF1.

Predicting neurofibromatosis type 1 risk among

children with isolated café-au-lait macules.

J Am Acad Dermatol

2017 Mar 15;[EPub Ahead

of Print], S Ben-Shachar, T Dubov, H Toledano-Al-

hadef, et al.

COMMENT

By Shay Ben Shachar

MD

A

lthough isolated café-au-lait mac-

ules (CALMs) are a common skin

finding, they are an early feature

of neurofibromatosis type 1 (NF1) and

usually serve as its presenting sign. In

the absence of a positive family history,

it is impossible to determine whether

young children presenting with isolated

CALMs have NF1 or not. Such determi-

nation can be made only after a further

follow-up or performance of a genetic

analysis. We proposed a diagnostic

algorithm to allow for the categorisation

of individuals with isolated CALMs as

being at low or high risk for having NF1.

Individuals with isolated CALMs and

an eventual diagnosis of NF1 (based

on molecular analysis or clinical diag-

nosis achieved later) presented at a

younger age to the neurofibromatosis

clinic or the diagnostic lab, had higher

frequency of six or more CALMs, and a

lower chance of having atypical CALMs

at presentation, compared with those

who did not have an eventual diagno-

sis of NF1. According to the algorithm

developed, children older than 29

months with isolated CALMs and at

least one atypical CALM or fewer than

six CALMs have about a 1% risk for con-

stitutional NF1 while children under 29

months old with isolated CALMs have

a high risk of about 80% for having

NF1. This simple algorithm enables cat-

egorisation of individuals with isolated

CALMs as being at low or high risk for

having NF1.

Dr Shachar is a paediatrician

practising in Houston, Texas.

PAEDIATRIC DERMATOLOGY

22

PRACTICEUPDATE DERMATOLOGY